Kharitonov Michael

Avg. Two Year Performance

(77%) Avg. Purchase Return
(33%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(19%)90%(< 1%)(77%)
Purchase Success Rate0 of 10 of 11 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Scorpius Holdings, Inc.

Drugs » Biotechnology

Director:

Holdings: 949.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--